Literature DB >> 8435239

Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy.

S al-Mahdawi1, S Chamberlain, J Cleland, P Nihoyannopoulos, D Gilligan, J French, L Choudhury, R Williamson, C Oakley.   

Abstract

OBJECTIVE: To investigate the molecular genetic basis of the cause of disease in a family with hypertrophic cardiomyopathy.
BACKGROUND: Mutation within the beta cardiac myosin heavy chain gene has been shown to be the pathogenetic mechanism underlying the disease in several families, though clear evidence of heterogeneity has been reported. PATIENTS: A family with a history of hypertrophic cardiomyopathy. RESULTS AND
CONCLUSION: This paper reports a mutation at aminoacid position 908 within exon 23 of the beta cardiac myosin heavy chain gene, resulting in a conversion of a leucine to valine. This base substitution was identified in an individual with a confirmed family history but with equivocal symptoms of the disease. Inheritance of the mutation by his symptom free juvenile offspring demonstrates the application of the technique to presymptomatic diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435239      PMCID: PMC1024940          DOI: 10.1136/hrt.69.2.136

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  32 in total

1.  Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support.

Authors:  T Hultman; S Ståhl; E Hornes; M Uhlén
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

2.  Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape.

Authors:  H M Lever; R F Karam; P J Currie; B P Healy
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

3.  Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.

Authors:  W J McKenna; R C Franklin; P Nihoyannopoulos; K C Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

4.  Nucleotide sequence of full length human embryonic myosin heavy chain cDNA.

Authors:  M Eller; H H Stedman; J E Sylvester; S H Fertels; N A Rubinstein; A M Kelly; S Sarkar
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

5.  Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families.

Authors:  S C Greaves; A H Roche; J M Neutze; R M Whitlock; A M Veale
Journal:  Br Heart J       Date:  1987-09

Review 6.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2).

Authors:  B J Maron; R O Bonow; R O Cannon; M B Leon; S E Epstein
Journal:  N Engl J Med       Date:  1987-04-02       Impact factor: 91.245

Review 7.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

Authors:  B J Maron; R O Bonow; R O Cannon; M B Leon; S E Epstein
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

8.  Characterization of cDNA coding for the complete light meromyosin portion of a rabbit fast skeletal muscle myosin heavy chain.

Authors:  K Maeda; G Sczakiel; A Wittinghofer
Journal:  Eur J Biochem       Date:  1987-08-17

9.  Complete nucleotide sequence and deduced polypeptide sequence of a nonmuscle myosin heavy chain gene from Acanthamoeba: evidence of a hinge in the rodlike tail.

Authors:  J A Hammer; B Bowers; B M Paterson; E D Korn
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

10.  Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood.

Authors:  J A Panza; B J Maron
Journal:  Am J Cardiol       Date:  1989-05-15       Impact factor: 2.778

View more
  8 in total

1.  Genetic testing for familial hypertrophic cardiomyopathy in newborn infants.

Authors:  M P Ryan; J French; S al-Mahdawi; P Nihoyannopoulos; J G Cleland; C M Oakley; P S Harper; A Clarke; J Davis; L Grigg
Journal:  BMJ       Date:  1995-04-01

2.  Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene.

Authors:  E Dausse; M Komajda; L Fetler; O Dubourg; C Dufour; L Carrier; C Wisnewsky; J Bercovici; C Hengstenberg; S al-Mahdawi
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 3.  Multiple disease genes cause hypertrophic cardiomyopathy.

Authors:  H Watkins
Journal:  Br Heart J       Date:  1994-12

4.  Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families.

Authors:  W J McKenna; P Spirito; M Desnos; O Dubourg; M Komajda
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

5.  The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.

Authors:  S al-Mahdawi; S Chamberlain; L Chojnowska; E Michalak; P Nihoyannopoulos; M Ryan; B Kusnierczyk; J A French; D M Gilligan; J Cleland
Journal:  Br Heart J       Date:  1994-08

6.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Authors:  R Anan; G Greve; L Thierfelder; H Watkins; W J McKenna; S Solomon; C Vecchio; H Shono; S Nakao; H Tanaka
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

7.  Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy.

Authors:  I Rayment; H M Holden; J R Sellers; L Fananapazir; N D Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 8.  Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies.

Authors:  Maria Giovanna Colombo; Nicoletta Botto; Simona Vittorini; Umberto Paradossi; Maria Grazia Andreassi
Journal:  Cardiovasc Ultrasound       Date:  2008-12-19       Impact factor: 2.062

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.